TherapeuticsMD, Inc. — Director's Dealing 2019

May 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2019-05-13

Reporting Person: Thompson Tommy G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-13	Common Stock	P	2400	$3.34	Acquired	685900	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1001	Indirect
Common Stock	3555	Direct

Footnotes

F1: Owned by Thompson Family Investments, LLC an entity solely owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.

F2: Owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.